¼¼°èÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð Á¶»ç : ¿ø·áº°, Á¦Ç° À¯Çüº°, ¿ëµµº°, Ư¼ºº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)
Global Craniomaxillofacial Implants Market Size study, by Raw Material, By Product Type, By Application, By Property and Regional Forecasts 2022-2032
»óǰÄÚµå
:
1486447
¸®¼Ä¡»ç
:
Bizwit Research & Consulting LLP
¹ßÇàÀÏ
:
2024³â 05¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 200 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¼¼°è µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀåÀº 2023³â ¾à 14¾ï 9,000¸¸ ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇß°í, ¿¹Ãø ±â°£ÀÎ 2024³âºÎÅÍ 2032³â±îÁö 6.40% ÀÌ»óÀÇ °ßÁ¶ÇÑ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
µÎ°³¾Ç¾È¸é ÀÓÇöõÆ®´Â µÎ°³°ñ, ¾ó±¼(»ó¾Ç ¹× ÇϾÇ) ¹× °ü·Ã ±¸Á¶¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÀÌ»ó, ¼Õ»ó ¶Ç´Â ÀÌ»ó¿¡ ´ëóÇϱâ À§ÇÑ ¿Ü°úÀû °³ÀÔ¿¡ Ȱ¿ëµÇ´Â ¸ÂÃãÇü ÀÇ·á±â±âÀÔ´Ï´Ù. ±× ¸ñÀûÀº ¸Ó¸®¿Í ¾ó±¼ÀÇ »À, ¿¬Á¶Á÷ ¹× ÁöÁö ¿ä¼Ò¸¦ Æ÷ÇÔÇÑ µÎ°³¾È¸é ºÎÀ§ÀÇ ¿ø·¡ ¸ð¾ç, ±¸¼º ¹× ±â´ÉÀ» º¹¿øÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀÓÇöõÆ®´Â ¿µ±¸Àû ¶Ç´Â ÀϽÃÀûÀ¸·Î ü³»¿¡ À̽ÄÇÒ ¼ö ÀÖ¾î Àû¿ë ¹üÀ§°¡ ³Ð°í, ÀûÀýÇÏ´Ù°í ÆÇ´ÜµÇ¸é Á¦°ÅÇÒ ¼ö ÀÖÀ¸¸ç, CT ½ºÄµ ¹× 3D À̹Ì¡°ú °°Àº ¿µ»ó ±â¼úÀÇ ±Þ¼ÓÇÑ ¹ßÀü°ú ¼ö¼ú °èȹ ¹× ½Ã¹Ä·¹À̼ÇÀ» À§ÇÑ °í±Þ ¼ÒÇÁÆ®¿þ¾îÀÇ °³¹ß·Î ÀÎÇØ ¿Ü°ú ÀÇ»ç´Â °¢ ȯÀÚÀÇ °íÀ¯ÇÑ ÇØºÎÇÐÀû ±¸Á¶¿¡ ¸Â´Â ¸ÂÃãÇü ÀÓÇöõÆ®¸¦ ¸¸µé ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. µû¶ó¼ ȯÀÚº° ¸ÂÃãÇü ÀÓÇöõÆ® ¼Ö·ç¼ÇÀ¸·ÎÀÇ ÀüȯÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀº ¼¼°è µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀåÀÇ ¼ºÀå¿¡ ÀÖ¾î Áß¿äÇÑ Ãß¼¼ÀÔ´Ï´Ù.
Àα¸ °í·ÉÈ¿¡ µû¶ó µÎ°³¾Ç¾È¸é ºÎÀ§¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ³ëÈ °ü·Ã Áúȯ ¹× ÅðÇ༺ ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àα¸ Åë°èÇÐÀû Ư¼ºÀº ¾È¸é Àç°Ç ¹× Åα³Á¤ ¼ö¼ú°ú °°Àº ½Ã¼úÀ» À§ÇÑ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ¼ö¿ä¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹Ì¿ë °È¸¦ À§ÇÑ ¾È¸é ÀÓÇöõÆ® µî µÎ°³¾Ç¾È¸é ºÎÀ§ °ü·Ã ½É¹ÌÀû ½Ã¼ú¿¡ ´ëÇÑ Àνİú ¼ö¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ƯÈ÷ ¹Ì¿ë ¸ñÀûÀ¸·Î ¼³°èµÈ ÀÓÇöõÆ®¿¡ ´ëÇÑ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¼¼°è µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀåÀº ÃÖ¼Òħ½ÀÀû Àç°Ç ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÀÓÇöõÆ® ¼³°è ¹× Àç·áÀÇ Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀü, ¿Ü»ó »ç·Ê, ±³Åë »ç°í, ¼±Ãµ¼º ¾È¸é ±âÇü ¹ß»ý·ü Áõ°¡ µîÀÇ ÁÖ¿ä ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí Àü ¼¼°èÀûÀ¸·Î µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® äÅÿ¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÅÈï±¹ÀÇ ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·°ú ÀÇ·á ÀÎÇÁ¶ó ºÎÁ·Àº 2022³âºÎÅÍ 2032³â±îÁö ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°è µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå Á¶»ç¿¡¼ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀ¸·Î´Â ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, À¯·´, Áß³²¹Ì ¹× ±âŸ Áö¿ªÀÌ Æ÷ÇԵǸç, 2023³â¿¡´Â ºÏ¹Ì°¡ Àüü ¼¼°è µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå¿¡¼ ½ÃÀå ¼öÀÍ Ãø¸é¿¡¼ ¼±µÎ¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â µÎ°³¾Ç¾È¸é ÁúȯÀÇ À¯º´·ü Áõ°¡, À¯¸®ÇÑ ÀÇ·á º¸Çè Á¤Ã¥, ÀÓÇöõÆ® Á¦Á¶¸¦ À§ÇÑ 3D ÇÁ¸°ÆÃ ±â¼úÀÇ º¸±Þ¿¡ ±âÀÎÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ªÀÇ ½ÅÁ¦Ç° Ãâ½Ã¿Í ½ºÆ÷Ã÷ °ü·Ã ºÎ»ó ¹ß»ý·ü Áõ°¡µµ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÇÑÆí, À¯·´ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È »ó´çÇÑ CAGR·Î »ó´çÇÑ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ º¸°í¼¿¡ Æ÷ÇÔµÈ ÁÖ¿ä ½ÃÀå ±â¾÷Àº ´ÙÀ½°ú °°½À´Ï´Ù.
- Stryker Corporation
- Medtronic plc
- OsteoMed L.P
- Johnson & Johnson Inc.
- Zimmer Biomet Holdings, Inc.
- Calavera Surgical Design
- Integra LifeSciences Holdings Corporation
- KLS Martin
- Matrix Surgical USA
- Medartis AG
¸ñÂ÷
Á¦1Àå ¼¼°èÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå Á¤ÀÇ¿Í Á¶»çÀÇ ÀüÁ¦Á¶°Ç
- Á¶»ç ¸ñÀû
- ½ÃÀåÀÇ Á¤ÀÇ
- Á¶»çÀÇ ÀüÁ¦Á¶°Ç
- Æ÷ÇÔ »çÇ× ¹× Á¦¿Ü »çÇ×
- Á¦ÇÑ »çÇ×
- °ø±Þ »çÀÌ ºÐ¼®
- °¡¿ë¼º
- ÀÎÇÁ¶ó
- ±ÔÁ¦ ȯ°æ
- ½ÃÀå °æÀï
- °æÁ¦¼º(¼ÒºñÀÚ ½ÃÁ¡)
- ¼ö¿äÃø ºÐ¼®
- ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
- ±â¼ú Áøº¸
- ģȯ°æ
- ¼ÒºñÀÚ Àǽİú ¼ö¿ë
- Á¶»ç ¹æ¹ý
- Á¶»ç ´ë»ó³âµµ
- ÅëÈ È¯»êÀ²
Á¦2Àå ÁÖ¿ä ¿ä¾à
- ¼¼°èÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2032³â)
- Áö¿ªº° °³¿ä
- ºÎ¹®º° °³¿ä
- ¿øÀç·áº°
- Á¦Ç° À¯Çüº°
- ¿ëµµº°
- Ư¼ºº°
- ÁÖ¿ä µ¿Çâ
- ºÒȲÀÇ ¿µÇâ
- ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È
Á¦3Àå ¼¼°èÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
- ½ÃÀå ±âȸ
Á¦4Àå ¼¼°èÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå »ê¾÷ ºÐ¼®
- Porter's Five Forces ¸ðµ¨
- °ø±Þ ±â¾÷ÀÇ ±³¼··Â
- ¹ÙÀ̾îÀÇ ±³¼··Â
- ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
- ´ëüǰÀÇ À§Çù
- °æÀï ±â¾÷°£ °æÀï °ü°è
- Porter's Five Forces ¸ðµ¨¿¡ ´ëÇÑ ¹Ì·¡Àû Á¢±Ù
- Porter's Five ForcesÀÇ ¿µÇ⠺м®
- PESTEL ºÐ¼®
- Á¤Ä¡
- °æÁ¦
- »çȸ
- 񃬣
- ȯ°æ
- ¹ý·ü
- ÁÖ¿ä ÅõÀÚ ±âȸ
- ÁÖ¿ä ¼º°ø Àü·«
- ÆÄ±«Àû µ¿Çâ
- ¾÷°è Àü¹®°¡ÀÇ °ßÇØ
- ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È
Á¦5Àå ¼¼°èÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ¿øÀç·áº°, 2022-2032³â
- ±Ý¼Ó
- ¼¼¶ó¹Í
- Æú¸®¸Ó
- ¹ÙÀÌ¿À¼ÒÀç
Á¦6Àå ¼¼°èÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¦Ç° À¯Çüº°, 2022-2032³â
- ½ºÅ©·ù
- ¸Þ½Ã
- Ç÷¹ÀÌÆ®
- °ñÀÌ½ÄÆí
- °æ¸· ¼öº¹
- ±âŸ
Á¦7Àå ¼¼°èÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ¿ëµµº°, 2022-2032³â
- ³»ºÎ °íÁ¤ Àåºñ
- ü¿Ü °íÁ¤ Àåºñ
Á¦8Àå ¼¼°èÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Ư¼ºº°, 2022-2032³â
- Èí¼ö¼º °íÁ¤±¸
- ºñÈí¼ö¼º °íÁ¤±¸
Á¦9Àå ¼¼°èÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°, 2022-2032³â
- ºÏ¹ÌÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- ¹Ì±¹
- ¿øÀç·á ³»¿ª ±Ô¸ð¿Í ¿¹Ãø, 2022-2032³â
- Á¦Ç° À¯Çü ³»¿ª ±Ô¸ð¿Í ¿¹Ãø, 2022-2032³â
- ¿ëµµ ³»¿ª ±Ô¸ð¿Í ¿¹Ãø, 2022-2032³â
- Ư¼º ³»¿ª ±Ô¸ð¿Í ¿¹Ãø, 2022-2032³â
- ij³ª´Ù µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- À¯·´ÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- ¿µ±¹ÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- µ¶ÀÏÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- ÇÁ¶û½ºÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- ½ºÆäÀÎÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- ÀÌÅ»¸®¾ÆÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- ±âŸ À¯·´ÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- Áß±¹ÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- ÀεµÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- ÀϺ»ÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- È£ÁÖÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- Çѱ¹ÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- ºê¶óÁúÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- ¸ß½ÃÄÚÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- »ç¿ìµð¾Æ¶óºñ¾ÆÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹ÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ µÎ°³¾Ç¾È¸é ÀÓÇöõÆ® ½ÃÀå
Á¦10Àå °æÀï Á¤º¸
- ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
- ÁÖ¿ä ½ÃÀå Àü·«
- ±â¾÷ °³¿ä
- Stryker Corporation
- ÁÖ¿ä Á¤º¸
- °³¿ä
- À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì)
- Á¦Ç° °³¿ä
- ½ÃÀå Àü·«
- Medtronic plc
- OsteoMed L.P
- Johnson & Johnson Inc.
- Zimmer Biomet Holdings, Inc
- Calavera Surgical Design
- Integra LifeSciences Holdings Corporation
- KLS Martin
- Matrix Surgical USA
- Medartis AG
Á¦11Àå Á¶»ç °úÁ¤
- Á¶»ç °úÁ¤
- µ¥ÀÌÅÍ ¸¶ÀÌ´×
- ºÐ¼®
- ½ÃÀå ÃßÁ¤
- °ËÁõ
- ÃâÆÇ
- Á¶»ç ¼Ó¼º
LSH
¿µ¹® ¸ñÂ÷
Global Craniomaxillofacial Implants Market is valued approximately at USD 1.49 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.40% over the forecast period 2024-2032. Craniomaxillofacial implants are customized medical instruments utilized in surgical interventions to address abnormalities, injuries, or anomalies impacting the skull (cranium), face (maxilla and mandible), and related structures. Their purpose is to reinstate the inherent shape, configuration, and function of the craniofacial region, encompassing the bones, soft tissues, and supporting elements of the head and face. These implants can be either permanently or temporarily embedded in the body, providing versatility in their application and removal as deemed appropriate. The rapid advancement in imaging technologies, such as CT scans and 3D imaging, along with the development of sophisticated software for surgical planning and simulation, have enabled surgeons to create personalized implants tailored to each patient's unique anatomy. Accordingly, the rising shift towards patient-specific and customized implant solutions is a key trend for the growth of the Global Craniomaxillofacial Implants Market.
There is an increased prevalence of age-related conditions and degenerative diseases affecting the craniofacial region with the aging population. This demographic trend contributes to the demand for craniomaxillofacial implants for procedures such as facial reconstruction and orthognathic surgery. Also, there is a growing awareness and acceptance of aesthetic procedures related to the craniomaxillofacial region, such as facial implants for cosmetic enhancement. This trend drives the demand for implants designed specifically for aesthetic purposes. The global craniomaxillofacial implants market is propelled by key factors include the growing demand for minimally invasive reconstruction surgeries, continuous technological advancements in implant design and materials, and the escalating incidence of trauma cases, road accidents, and congenital facial deformities. These factors drive the market's growth and influence the adoption of craniomaxillofacial implants worldwide. However, lack of skilled professionals, along with inadequate healthcare infrastructure in emerging nations is anticipated to stifle market growth between 2022 and 2032.
The key regions considered for the global Craniomaxillofacial Implants Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America is expected to maintain its leading position in terms of market revenue across the global Craniomaxillofacial Implants Market. This is due to the increasing prevalence of craniomaxillofacial disorders, favorable health reimbursement policies, and the widespread adoption of 3D printing technology for implant manufacturing. Also, this growth is driven by new product launches and the rising incidence of sports-related injuries in the region. On the other hand, the Europe craniomaxillofacial implants market is projected to witness significant growth with a considerable compound annual growth rate (CAGR) during the forecast period.
Major market player included in this report are:
- Stryker Corporation
- Medtronic plc
- OsteoMed L.P
- Johnson & Johnson Inc.
- Zimmer Biomet Holdings, Inc
- Calavera Surgical Design
- Integra LifeSciences Holdings Corporation
- KLS Martin
- Matrix Surgical USA
- Medartis AG
The detailed segments and sub-segment of the market are explained below:
By Raw Material
- Metals
- Ceramics
- Polymers
- Biomaterials
By Product Type
- Screws
- Mesh
- Plates
- Bone Graft
- Dural Repair
- Others
By Application
- Internal Fixators
- External Fixators
By Property
- Resorbable Fixators
- Non-resorbable Fixators
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- Saudi Arabia
- South Africa
- RoMEA
Years considered for the study are as follows:
- Historical year - 2022
- Base year - 2023
- Forecast period - 2024 to 2032
Key Takeaways:
- Market Estimates & Forecast for 10 years from 2022 to 2032.
- Annualized revenues and regional level analysis for each market segment.
- Detailed analysis of geographical landscape with Country level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of competitive structure of the market.
- Demand side and supply side analysis of the market.
Table of Contents
Chapter 1.Global Craniomaxillofacial Implants Market Definition and Research Assumptions
- 1.1.Research Objective
- 1.2.Market Definition
- 1.3.Research Assumptions
- 1.3.1.Inclusion & Exclusion
- 1.3.2.Limitations
- 1.3.3.Supply Side Analysis
- 1.3.3.1.Availability
- 1.3.3.2.Infrastructure
- 1.3.3.3.Regulatory Environment
- 1.3.3.4.Market Competition
- 1.3.3.5.Economic Viability (Consumer's Perspective)
- 1.3.4.Demand Side Analysis
- 1.3.4.1.Regulatory frameworks
- 1.3.4.2.Technological Advancements
- 1.3.4.3.Environmental Considerations
- 1.3.4.4.Consumer Awareness & Acceptance
- 1.4.Estimation Methodology
- 1.5.Years Considered for the Study
- 1.6.Currency Conversion Rates
Chapter 2.Executive Summary
- 2.1.Global Craniomaxillofacial Implants Market Size & Forecast (2022- 2032)
- 2.2.Regional Summary
- 2.3.Segmental Summary
- 2.3.1.By Raw Material
- 2.3.2.By Product Type
- 2.3.3.By Application
- 2.3.4.By Property
- 2.4.Key Trends
- 2.5.Recession Impact
- 2.6.Analyst Recommendation & Conclusion
Chapter 3.Global Craniomaxillofacial Implants Market Dynamics
- 3.1.Market Drivers
- 3.2.Market Challenges
- 3.3.Market Opportunities
Chapter 4.Global Craniomaxillofacial Implants Market: Industry Analysis
- 4.1.Porter's 5 Force Model
- 4.1.1.Bargaining Power of Suppliers
- 4.1.2.Bargaining Power of Buyers
- 4.1.3.Threat of New Entrants
- 4.1.4.Threat of Substitutes
- 4.1.5.Competitive Rivalry
- 4.1.6.Futuristic Approach to Porter's 5 Force Model
- 4.1.7.Porter's 5 Force Impact Analysis
- 4.2.PESTEL Analysis
- 4.2.1.Political
- 4.2.2.Economic
- 4.2.3.Social
- 4.2.4.Technological
- 4.2.5.Environmental
- 4.2.6.Legal
- 4.3.Top investment opportunity
- 4.4.Top winning strategies
- 4.5.Disruptive Trends
- 4.6.Industry Expert Perspective
- 4.7.Analyst Recommendation & Conclusion
Chapter 5.Global Craniomaxillofacial Implants Market Size & Forecasts by Raw Material 2022-2032
- 5.1.Metals
- 5.2.Ceramics
- 5.3.Polymers
- 5.4.Biomaterials
Chapter 6.Global Craniomaxillofacial Implants Market Size & Forecasts by Product Type 2022-2032
- 6.1.Screws
- 6.2.Mesh
- 6.3.Plates
- 6.4.Bone Graft
- 6.5.Dural Repair
- 6.6.Others
Chapter 7.Global Craniomaxillofacial Implants Market Size & Forecasts by Application 2022-2032
- 7.1.Internal Fixators
- 7.2.External Fixators
Chapter 8.Global Craniomaxillofacial Implants Market Size & Forecasts by Property 2022-2032
- 8.1.Resorbable Fixators
- 8.2.Non-resorbable Fixators
Chapter 9.Global Craniomaxillofacial Implants Market Size & Forecasts by Region 2022-2032
- 9.1.North America Craniomaxillofacial Implants Market
- 9.1.1.U.S. Craniomaxillofacial Implants Market
- 9.1.1.1. Raw Material breakdown size & forecasts, 2022-2032
- 9.1.1.2.Product Type breakdown size & forecasts, 2022-2032
- 9.1.1.3.Application breakdown size & forecasts, 2022-2032
- 9.1.1.4.Property breakdown size & forecasts, 2022-2032
- 9.1.2.Canada Craniomaxillofacial Implants Market
- 9.2.Europe Craniomaxillofacial Implants Market
- 9.2.1.U.K. Craniomaxillofacial Implants Market
- 9.2.2.Germany Craniomaxillofacial Implants Market
- 9.2.3.France Craniomaxillofacial Implants Market
- 9.2.4.Spain Craniomaxillofacial Implants Market
- 9.2.5.Italy Craniomaxillofacial Implants Market
- 9.2.6.Rest of Europe Craniomaxillofacial Implants Market
- 9.3.Asia-Pacific Craniomaxillofacial Implants Market
- 9.3.1.China Craniomaxillofacial Implants Market
- 9.3.2.India Craniomaxillofacial Implants Market
- 9.3.3.Japan Craniomaxillofacial Implants Market
- 9.3.4.Australia Craniomaxillofacial Implants Market
- 9.3.5.South Korea Craniomaxillofacial Implants Market
- 9.3.6.Rest of Asia Pacific Craniomaxillofacial Implants Market
- 9.4.Latin America Craniomaxillofacial Implants Market
- 9.4.1.Brazil Craniomaxillofacial Implants Market
- 9.4.2.Mexico Craniomaxillofacial Implants Market
- 9.4.3.Rest of Latin America Craniomaxillofacial Implants Market
- 9.5.Middle East & Africa Craniomaxillofacial Implants Market
- 9.5.1. Saudi Arabia Craniomaxillofacial Implants Market
- 9.5.2. South Africa Craniomaxillofacial Implants Market
- 9.5.3.Rest of Middle East & Africa Craniomaxillofacial Implants Market
Chapter 10.Competitive Intelligence
- 10.1.Key Company SWOT Analysis
- 10.2.Top Market Strategies
- 10.3.Company Profiles
- 10.3.1.Stryker Corporation
- 10.3.1.1.Key Information
- 10.3.1.2.Overview
- 10.3.1.3.Financial (Subject to Data Availability)
- 10.3.1.4.Product Summary
- 10.3.1.5.Market Strategies
- 10.3.2.Medtronic plc
- 10.3.3.OsteoMed L.P
- 10.3.4.Johnson & Johnson Inc.
- 10.3.5.Zimmer Biomet Holdings, Inc
- 10.3.6.Calavera Surgical Design
- 10.3.7.Integra LifeSciences Holdings Corporation
- 10.3.8.KLS Martin
- 10.3.9.Matrix Surgical USA
- 10.3.10.Medartis AG
Chapter 11.Research Process
- 11.1.Research Process
- 11.1.1.Data Mining
- 11.1.2.Analysis
- 11.1.3.Market Estimation
- 11.1.4.Validation
- 11.1.5.Publishing
- 11.2.Research Attributes
°ü·ÃÀÚ·á